Cargando…

Characterization of methadone as a β-arrestin-biased μ-opioid receptor agonist

BACKGROUND: Methadone is a unique µ-opioid receptor agonist. Although several researchers have insisted that the pharmacological effects of methadone are mediated through the blockade of NMDA receptor, the underlying mechanism by which methadone exerts its distinct pharmacological effects compared t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Doi, Seira, Mori, Tomohisa, Uzawa, Naoki, Arima, Takamichi, Takahashi, Tomoyuki, Uchida, Masashi, Yawata, Ayaka, Narita, Michiko, Uezono, Yasuhito, Suzuki, Tsutomu, Narita, Minoru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4956382/ https://www.ncbi.nlm.nih.gov/pubmed/27317580 http://dx.doi.org/10.1177/1744806916654146

Ejemplares similares

Usefulness for the combination of G protein- and β-arrestin-biased ligands of μ-opioid receptors: Prevention of antinociceptive tolerance
por: Mori, Tomohisa, et al.
Publicado: (2017)

Evaluation of the Intracellular Signaling Activities of κ-Opioid Receptor Agonists, Nalfurafine Analogs; Focusing on the Selectivity of G-Protein- and β-Arrestin-Mediated Pathways
por: Yamaguchi, Masahiro, et al.
Publicado: (2022)

PS13. Role of the hypothalamic µ-opioidergic systems in the anti-tumor immune response
por: Hamada, Yusuke, et al.
Publicado: (2016)

Agonist dependency of the second phase access of β-arrestin 2 to the heteromeric µ-V1b receptor
por: Ngamlertwong, Nuttawadee, et al.
Publicado: (2021)

Functional map of arrestin binding to phosphorylated opsin, with and without agonist
por: Peterhans, Christian, et al.
Publicado: (2016)

Ketamine Improves Desensitization of µ-Opioid Receptors Induced by Repeated Treatment with Fentanyl but Not with Morphine
por: Mizobuchi, Yusuke, et al.
Publicado: (2022)

Pharmacological Characterization of µ-Opioid Receptor Agonists with Biased G Protein or β-Arrestin Signaling, and Computational Study of Conformational Changes during Receptor Activation
por: Piekielna-Ciesielska, Justyna, et al.
Publicado: (2020)

The β-blocker Nebivolol Is a GRK/β-arrestin Biased Agonist
por: Erickson, Catherine E., et al.
Publicado: (2013)

Corrigendum: Functional map of arrestin binding to phosphorylated opsin, with and without agonist
por: Peterhans, Christian, et al.
Publicado: (2016)

β-Arrestin–Biased Angiotensin II Receptor Agonists for COVID-19
por: Manglik, Aashish, et al.
Publicado: (2020)

Elucidation of the mechanisms underlying tumor aggravation by the activation of stress-related neurons in the paraventricular nucleus of the hypothalamus
por: Yoshida, Sara, et al.
Publicado: (2023)

Enhanced BRET Technology for the Monitoring of Agonist-Induced and Agonist-Independent Interactions between GPCRs and β-Arrestins
por: Kocan, Martina, et al.
Publicado: (2011)

Plasma turbulence in the solar system
por: Narita, Yasuhito
Publicado: (2012)

Space–time structure and wavevector anisotropy in space plasma turbulence
por: Narita, Yasuhito
Publicado: (2018)

к Opioids inhibit tumor angiogenesis by suppressing VEGF signaling
por: Yamamizu, Kohei, et al.
Publicado: (2013)

Tumor suppression and improvement in immune systems by specific activation of dopamine D1-receptor-expressing neurons in the nucleus accumbens
por: Sato, Daisuke, et al.
Publicado: (2022)

Atomic-Level Characterization of the Methadone-Stabilized Active Conformation of µ-Opioid Receptor
por: Kapoor, Abhijeet, et al.
Publicado: (2020)

In Vitro Analyses of Spinach-Derived Opioid Peptides, Rubiscolins: Receptor Selectivity and Intracellular Activities through G Protein- and β-Arrestin-Mediated Pathways
por: Karasawa, Yusuke, et al.
Publicado: (2021)

Agonist mediated internalization of M(2 )mAChR is β-arrestin-dependent
por: Jones, Kymry T, et al.
Publicado: (2006)

Determining the Effects of Differential Expression of GRKs and β-arrestins on CLR-RAMP Agonist Bias
por: Pearce, Abigail, et al.
Publicado: (2022)

Increased apoptosis and hypomyelination in cerebral white matter of macular mutant mouse brain
por: Takikita, Shoichi, et al.
Publicado: (2015)

ERRγ agonist under mechanical stretching manifests hypertrophic cardiomyopathy phenotypes of engineered cardiac tissue through maturation
por: Fujiwara, Yuya, et al.
Publicado: (2023)

Unique pharmacodynamic properties and low abuse liability of the μ-opioid receptor ligand (S)-methadone
por: Michaelides, Michael, et al.
Publicado: (2023)

Oxytocin Is a Positive Allosteric Modulator of κ-Opioid Receptors but Not δ-Opioid Receptors in the G Protein Signaling Pathway
por: Miyano, Kanako, et al.
Publicado: (2021)

Distinct Profiles of Desensitization of µ-Opioid Receptors Caused by Remifentanil or Fentanyl: In Vitro Assay with Cells and Three-Dimensional Structural Analyses
por: Uezono, Eiko, et al.
Publicado: (2023)

Intrinsic Resistance to 5-Fluorouracil in a Brain Metastatic Variant of Human Breast Cancer Cell Line, MDA-MB-231BR
por: Sagara, Atsunobu, et al.
Publicado: (2016)

Core engagement with β-arrestin is dispensable for agonist-induced vasopressin receptor endocytosis and ERK activation
por: Kumari, Punita, et al.
Publicado: (2017)

Exploration of beta-arrestin isoform signaling pathways in delta opioid receptor agonist-induced convulsions
por: Blaine, Arryn T., et al.
Publicado: (2022)

Ignavine: a novel allosteric modulator of the μ opioid receptor
por: Ohbuchi, Katsuya, et al.
Publicado: (2016)

Synthesis and Evaluation of Novel Biased μ-Opioid-Receptor (μOR) Agonists
por: Ma, Mengjun, et al.
Publicado: (2019)

Peripheral Opioid Antagonist Enhances the Effect of Anti-Tumor Drug by Blocking a Cell Growth-Suppressive Pathway In Vivo
por: Suzuki, Masami, et al.
Publicado: (2015)

Histone modification of pain-related gene expression in spinal cord neurons under a persistent postsurgical pain-like state by electrocautery
por: Katsuda, Yosuke, et al.
Publicado: (2021)

Relief of neuropathic pain by cell-specific manipulation of nucleus accumbens dopamine D1- and D2-receptor-expressing neurons
por: Sato, Daisuke, et al.
Publicado: (2022)

Impaired β-arrestin recruitment and reduced desensitization by non-catechol agonists of the D1 dopamine receptor
por: Gray, David L., et al.
Publicado: (2018)

Cannabinoid CB1 and CB2 Receptor-Mediated Arrestin Translocation: Species, Subtype, and Agonist-Dependence
por: Ibsen, Mikkel Søes, et al.
Publicado: (2019)

Biased β-Agonists Favoring Gs over β-Arrestin for Individualized Treatment of Obstructive Lung Disease
por: Tokmakova, Alina, et al.
Publicado: (2022)

β-Arrestin–Biased AT(1) Agonist TRV027 Causes a Neonatal-Specific Sustained Positive Inotropic Effect Without Increasing Heart Rate
por: Kashihara, Toshihide, et al.
Publicado: (2020)

Multiple Analyses of G-Protein Coupled Receptor (GPCR) Expression in the Development of Gefitinib-Resistance in Transforming Non-Small-Cell Lung Cancer
por: Kuzumaki, Naoko, et al.
Publicado: (2012)

Correction: Multiple Analyses of G-Protein Coupled Receptor (GPCR) Expression in the Development of Gefitinib-Resistance in Transforming Non-Small-Cell Lung Cancer
por: Kuzumaki, Naoko, et al.
Publicado: (2013)

Quality and quantity control of proteins in senescence
por: Narita, Masashi
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_nm4m2lc9mcv1tnp5ebft5o6tsk